Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Mesenchymal Stromal Cell Therapies for Neurodegenerative Diseases
Nathan P. Staff, David T. Jones, Wolfgang Singer
Mayo Clinic Proceedings (2019) Vol. 94, Iss. 5, pp. 892-905
Open Access | Times Cited: 133

Showing 1-25 of 133 citing articles:

Inflammation and aging: signaling pathways and intervention therapies
Xia Li, Chentao Li, Wanying Zhang, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 474
A Brief Overview of Global Trends in MSC-Based Cell Therapy
Dragomirka Jovic, Yingjia Yu, Dan Wang, et al.
Stem Cell Reviews and Reports (2022) Vol. 18, Iss. 5, pp. 1525-1545
Open Access | Times Cited: 164
Targeted Therapy for Inflammatory Diseases with Mesenchymal Stem Cells and Their Derived Exosomes: From Basic to Clinics
Shuo Wang, Biyu Lei, E Zhang, et al.
International Journal of Nanomedicine (2022) Vol. Volume 17, pp. 1757-1781
Open Access | Times Cited: 98
Intranasal delivery of BDNF-loaded small extracellular vesicles for cerebral ischemia therapy
Xin‐Fu Zhou, Xiaohui Deng, Mengfan Liu, et al.
Journal of Controlled Release (2023) Vol. 357, pp. 1-19
Open Access | Times Cited: 67
Mesenchymal stem cell secretome and extracellular vesicles for neurodegenerative diseases: Risk-benefit profile and next steps for the market access
Lorella Giovannelli, Elia Bari, Claudio Jommi, et al.
Bioactive Materials (2023) Vol. 29, pp. 16-35
Open Access | Times Cited: 47
Extracellular vesicles in nanomedicine and regenerative medicine: A review over the last decade
Saeid Moghassemi, Arezoo Dadashzadeh, Maria João Sousa, et al.
Bioactive Materials (2024) Vol. 36, pp. 126-156
Open Access | Times Cited: 30
Advances of Schwann cells in peripheral nerve regeneration: From mechanism to cell therapy
Chuqiao Wei, Yuanxin Guo, Zhen Ci, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 175, pp. 116645-116645
Open Access | Times Cited: 19
Mesenchymal stem cell-derived exosomal miR-223 regulates neuronal cell apoptosis
Hong Wei, Yuhao Xu, Qi Chen, et al.
Cell Death and Disease (2020) Vol. 11, Iss. 4
Open Access | Times Cited: 105
MSCs and Inflammatory Cells Crosstalk in Regenerative Medicine: Concerted Actions for Optimized Resolution Driven by Energy Metabolism
Valérie Planat‐Benard, Audrey Varin, Louis Casteilla
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 98
New therapeutic approaches of mesenchymal stem cells-derived exosomes
Jana Janočková, Lucia Slovinská, Denisa Harvanová, et al.
Journal of Biomedical Science (2021) Vol. 28, Iss. 1
Open Access | Times Cited: 96
Extracellular Vesicles as Nanotherapeutics for Parkinson’s Disease
Loredana Leggio, Greta Paternò, Silvia Vivarelli, et al.
Biomolecules (2020) Vol. 10, Iss. 9, pp. 1327-1327
Open Access | Times Cited: 92
HGF and MET: From Brain Development to Neurological Disorders
Claudia Desole, Simona Gallo, Annapia Vitacolonna, et al.
Frontiers in Cell and Developmental Biology (2021) Vol. 9
Open Access | Times Cited: 85
Application of Iron Oxide Nanoparticles in the Diagnosis and Treatment of Neurodegenerative Diseases With Emphasis on Alzheimer’s Disease
Shen Luo, Chi Ma, Mingqin Zhu, et al.
Frontiers in Cellular Neuroscience (2020) Vol. 14
Open Access | Times Cited: 84
Exosomes Derived from Adipose Mesenchymal Stem Cells Restore Functional Endometrium in a Rat Model of Intrauterine Adhesions
Shuangdan Zhao, Wenbo Qi, Jiahua Zheng, et al.
Reproductive Sciences (2020) Vol. 27, Iss. 6, pp. 1266-1275
Closed Access | Times Cited: 81
An Update of Palmitoylethanolamide and Luteolin Effects in Preclinical and Clinical Studies of Neuroinflammatory Events
Marika Cordaro, Salvatore Cuzzocrea, Rosalia Crupi
Antioxidants (2020) Vol. 9, Iss. 3, pp. 216-216
Open Access | Times Cited: 80
MSC-Derived Exosomes can Enhance the Angiogenesis of Human Brain MECs and Show Therapeutic Potential in a Mouse Model of Parkinson's Disease
Chunling Xue, Xuechun Li, Li Ba, et al.
Aging and Disease (2021) Vol. 12, Iss. 5, pp. 1211-1211
Open Access | Times Cited: 62
Mesenchymal stem cells in fibrotic diseases—the two sides of the same coin
Lei Qin, Nian Liu, Chaolemeng Bao, et al.
Acta Pharmacologica Sinica (2022) Vol. 44, Iss. 2, pp. 268-287
Open Access | Times Cited: 62
Sodium alginate/collagen/stromal cell-derived factor-1 neural scaffold loaded with BMSCs promotes neurological function recovery after traumatic brain injury
Shanshan Ma, Jiankang Zhou, Tuanjie Huang, et al.
Acta Biomaterialia (2021) Vol. 131, pp. 185-197
Closed Access | Times Cited: 59
Nanotherapeutic and Stem Cell Therapeutic Strategies in Neurodegenerative Diseases: A Promising Therapeutic Approach
Min Wei, Zhaofei Yang, Song Li, et al.
International Journal of Nanomedicine (2023) Vol. Volume 18, pp. 611-626
Open Access | Times Cited: 25
The Involvement of Neuroinflammation in the Onset and Progression of Parkinson’s Disease
Anamaria Jurcău, Felicia Liana Andronie-Cioară, Carmen Delia Nistor-Cseppento, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 19, pp. 14582-14582
Open Access | Times Cited: 22
Multiple system atrophy: an update and emerging directions of biomarkers and clinical trials
Min Liu, Zhiyao Wang, Huifang Shang
Journal of Neurology (2024) Vol. 271, Iss. 5, pp. 2324-2344
Open Access | Times Cited: 12
Mesenchymal Stem Cell Therapy for Alzheimer’s Disease
Arturo Hernández, Elisa García
Stem Cells International (2021) Vol. 2021, pp. 1-12
Open Access | Times Cited: 53
Mesenchymal stromal cell treatment attenuates repetitive mild traumatic brain injury-induced persistent cognitive deficits via suppressing ferroptosis
Dong Wang, Shishuang Zhang, Xintong Ge, et al.
Journal of Neuroinflammation (2022) Vol. 19, Iss. 1
Open Access | Times Cited: 35
Advantages of Rho-associated kinases and their inhibitor fasudil for the treatment of neurodegenerative diseases
Bao‐Guo Xiao, Cun‐Gen Ma, Qing Wang, et al.
Neural Regeneration Research (2022) Vol. 17, Iss. 12, pp. 2623-2623
Open Access | Times Cited: 32
Exosomes derived from bone marrow mesenchymal stem cells attenuate neurological damage in traumatic brain injury by alleviating glutamate-mediated excitotoxicity
Zerui Zhuang, Mingfa Liu, Jianming Luo, et al.
Experimental Neurology (2022) Vol. 357, pp. 114182-114182
Closed Access | Times Cited: 29
Page 1 - Next Page

Scroll to top